Opportunistic prostate cancer screening can lead to overdiagnosis of indolent diseases and invasive procedures. A cohort ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. It is primarily measured through a blood test, where normal levels are typically found ...

In a study involving more than 11,000 men enrolled in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, about one quarter of elevated prostate-specific antigen (PSA) results ...

Employing MRI-targeted biopsy instead of systematic biopsy reduces overdiagnosis of low-grade prostate cancer by more than half, although diagnoses may be delayed among a small minority of patients ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...